findmyKOL

Kashish Goel, MBBS

Enriched profile

Associate Professor of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center; Director of Transcatheter Valve Interventions · Vanderbilt University Medical Center

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Nashville, TN · Southeast · United StatesSpecialtyInterventional CardiologyFocusCardiac Valve Diseases and Treatments+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceNone verifiedPayments2021–2025NIH fundingNone on fileWhy? →

Kashish Goel is Associate Professor of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center; Director of Transcatheter Valve Interventions at Vanderbilt University Medical Center. OpenAlex indexes 178 publications with 6,277 citations (h-index 38); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 14 Oct 2026

Overview

Updated 14 Oct 2026

Kashish Goel is Associate Professor of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center. The public record shows 178 publications with 6,277 citations (h-index 38), centered on Cardiac Valve Diseases and Treatments, Aortic Disease and Treatment Approaches, Infective Endocarditis Diagnosis and Management. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 8 companies.

  • Most recent indexed publication: 2026 · Circulation. Cardiovascular interventions
  • Top research focus: Cardiac Valve Diseases and Treatments
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 8 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Cardiovascular Diseases1 trialVascular Diseases1 trialHeart Valve Diseases1 trialTricuspid Valve Insufficiency1 trialMitral Valve Insufficiency1 trialConstriction, Pathologic1 trialMitral Valve Stenosis1 trialCoronary Artery Disease / ACS

Research focus

OpenAlex concept fingerprint
Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment ApproachesInfective Endocarditis Diagnosis and ManagementCoronary Interventions and DiagnosticsCardiac Arrhythmias and Treatments

Works with

trial sponsors and companies reporting payments
Edwards Lifesciences CorporationClinical trials—Industry payments320Abbott LaboratoriesClinical trials—Industry payments90Medtronic, Inc.Clinical trials—Industry payments12Boston Scientific CorporationClinical trials—Industry payments4Teleflex LLCClinical trials—Industry payments4ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Clinical trials—Industry payments2Abbott Medical DevicesClinical trials1Industry payments—Arrow International, Inc.Clinical trials—Industry payments1Laplace Interventional, IncClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
178publications

Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.

6,277citations

Total citations across indexed works.

38h-index

Hirsch index (OpenAlex). i10-index 68.

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
8companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Public positions

sourced statements on record

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    77.5%
    Beta blocker17.4%
    Metoprolol Succinate35%Carvedilol35%Metoprolol Tartrate31%
    Part D≥23 patients
    Statin13.1%
    Atorvastatin Calcium74%Pravastatin Sodium13%Rosuvastatin Calcium13%
    Part D<11 patients

    + 12 more classes in this area

  • Blood & clotting

    13.7%
    P2Y12 inhibitor6.4%
    Clopidogrel83%Prasugrel Hcl17%
    Part D<11 patients
    Factor Xa inhibitor4.7%
    Eliquis75%Xarelto25%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    7.9%
    SGLT2 inhibitor3.9%
    Jardiance53%Farxiga47%
    Part D<11 patients
    Potassium supplement2.8%
    Potassium Chloride100%
    Part D<11 patients

    + 1 more class in this area

All 4 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Charanjit S. Rihal32Colin M. Barker25Brian R. Lindman25Sahil Khera23Tanush Gupta23Deepak L. Bhatt22Dhaval Sanjeev Kolte22Randal J. Thomas21Gregg C. Fonarow19Michael J. Reardon16Francisco Alejandro López-Jiménez15Molly Szerlip14Neal S. Kleiman14Raj Makkar14David R. Holmes14Kevin L. Greason14Mario Jorge Garcia13JoAnn M. Lindenfeld12Pinak Bipin Shah12Ashish S. Shah12Ray W. Squires12Basel Ramlawi11Michael J. Mack11Anoop Misra11Gilbert H.L. Tang11Jinnette Dawn Abbott11Ron Waksman10Syed Zaid10Vinod H. Thourani10George Petrossian10Brian K. Whisenant10Pedro Arturo Villablanca10Tsuyoshi Kaneko9Michael W.A. Chu9Paul Werner9Francesco Maisano9Paolo Denti9Isaac George9Vinayak Bapat9Thomas Modine9

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Associate Professor of Medicine

    Division of Cardiovascular Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.vumc.org ↗
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scai.org ↗
  • Fellow

    Society for Cardiovascular Angiography & Interventions

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scai.org ↗

Awards & honors

honors on the public record
  • 30 in Their 30s Award

    Vanderbilt University Medical Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scai.org ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.